IGM Biosciences, Inc. (41) | Business Finance (14)
Browse by Subcategory
Recent Contracts
-
Amended and Restated 2019 Employee Stock Purchase Plan, amended May 1, 2022, and forms of agreements thereunder
(Filed With SEC on May 9, 2022)
-
Underwriting Agreement, dated as of March 29, 2022, among IGM Biosciences, Inc. and the Representatives
(Filed With SEC on March 30, 2022)
-
Form of Pre-Funded Warrant
(Filed With SEC on December 9, 2020)
-
Form of Registration Rights Agreement, by and between the Registrant and certain securityholders
(Filed With SEC on December 7, 2020)
-
Amended and Restated Investor Rights Agreement, by and among the Registrant and certain of its stockholders, dated as of June 28, 2019
(Filed With SEC on August 19, 2019)
-
Nominating Agreement, by and among Redmile Biopharma Investments II, L.P., RAF, L.P., Redmile Strategic Master Fund, LP and the Registrant, dated as of June 28, 2019
(Filed With SEC on August 19, 2019)
-
Underwriting Agreement, dated as of December 8, 2020, by and among the Company and the Representatives
(Filed With SEC on December 9, 2020)
-
Amended and Restated 2019 Employee Stock Purchase Plan, amended July 30, 2020 and forms of agreements thereunder
(Filed With SEC on November 5, 2020)
-
Amended and Restated 2019 Employee Stock Purchase Plan
(Filed With SEC on August 3, 2020)
-
Form of Underwriting Agreement
(Filed With SEC on September 3, 2019)
-
Specimen common stock certificate of the Registrant
(Filed With SEC on September 3, 2019)
-
2019 Employee Stock Purchase Plan and forms of agreements thereunder, to be in effect upon completion of this offering
(Filed With SEC on September 3, 2019)
-
Amended and Restated 2010 Stock Plan and forms of agreement thereunder
(Filed With SEC on August 19, 2019)
-
Restricted Stock Grant Agreement, by and between Daniel Chen and the Registrant, dated as of December 30, 2018
(Filed With SEC on August 19, 2019)